ClinicalTrials.Veeva

Menu

Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory

N

Nevada Cancer Institute

Status

Unknown

Conditions

Early Stage Breast Cancer (Stage 0-III)

Treatments

Other: Exercise Regimen

Study type

Interventional

Funder types

Other

Identifiers

NCT01157130
NVCI 10-09

Details and patient eligibility

About

The proposed study compares the outcomes of a physical activity intervention begun at diagnosis, continuing through active cancer treatment and into six months of survivorship compared to the outcomes of a control group receiving limited information on activity.

Full description

Patients (with stage 0 to stage III breast cancer)receiving chemotherapy, radiation or both chemotherapy and radiation will be included in the study.Randomization will be stratified by disease stage at diagnosis, treatment modalities planned, and hormonal status. Each patient will have a weekly goal of 2000 calories burned and 18 MET-hours of exercise which can be achieved in 4 to 7 hours of physical activity per week. Resistance training, using weight machines and aerobic training using treadmills, elliptical trainers and stationary bicycles, will be utilized in the intervention group. The control group will receive basic information on physical activity but not be instructed. Any physical activity in this group will be self-reported. Change in C-reactive protein will be the primary endpoint. Changes in other laboratory values, DEXA measurements, and quality of life measurements will be secondary endpoints.

Enrollment

100 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Consent to participate in study
  2. Women aged 18 and older
  3. Stage 0 to III breast cancer prior to any treatment and at time of diagnosis
  4. Requires treatment that includes chemotherapy, radiation therapy or both chemotherapy and radiation therapy
  5. Adequate fitness to participate in a physical activity as assessed by the investigator
  6. Willing and able to participate in a prescribed exercise program

Exclusion criteria

  1. Metastatic breast cancer (Stage IV)
  2. Initiation of treatment regimen prior to enrollment
  3. Treatment for breast cancer not requiring chemotherapy or radiation therapy
  4. Patients who are pregnant (negative urine pregnancy test required at baseline to determine eligibility in women of child bearing potential).
  5. Currently lactating
  6. Do not read, understand, or speak English

Eligible participants will not be included if they have:

  1. known cardiac disease,
  2. uncontrolled hypertension,
  3. uncontrolled thyroid disease,
  4. diabetes mellitus,
  5. mental illness,
  6. infection,
  7. immune or endocrine abnormality,
  8. body weight reduction I10% in past 6 months, and
  9. positive exercise stress test.
  10. Major surgery within last 6 months that requires exercise restriction

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Intervention Group
Experimental group
Description:
Each patient will have a weekly goal of 2000 calories burned and 18 MET-hours of exercise which can be achieved in 4 to 7 hours of physical activity per week. Resistance training, using weight machines and aerobic training using treadmills, elliptical trainers and stationary bicycles, will be utilized in the intervention group.
Treatment:
Other: Exercise Regimen
Control Group
No Intervention group
Description:
The control group will receive basic information on physical activity but not be instructed.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems